{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:53:35Z","timestamp":1793134415672,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jacc.2017.07.725","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T14:15:38Z","timestamp":1503929738000},"page":"1262-1272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure"],"prefix":"10.1016","volume":"70","author":[{"given":"Damien","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Jokinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers E.F.","family":"Daubeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.07.725_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cardfail.2014.10.011","article-title":"Pediatric versus adult cardiomyopathy and heart failure-related hospitalizations: a value-based analysis","volume":"21","author":"Wittlieb-Weber","year":"2015","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2017.07.725_bib2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.07.725_bib3","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.07.725_bib4","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.07.725_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jacc.2013.11.059","article-title":"Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry","volume":"63","author":"Everitt","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.725_bib6","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/CIRCULATIONAHA.113.002767","article-title":"Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy","volume":"128","author":"Alexander","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.07.725_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/fca.13.66","article-title":"Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies","volume":"9","author":"Lipshultz","year":"2013","journal-title":"Future Cardiol"},{"key":"10.1016\/j.jacc.2017.07.725_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.cjca.2013.08.008","article-title":"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines","volume":"29","author":"Kantor","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2017.07.725_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary [corrected]","volume":"33","author":"Kirk","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2017.07.725_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1067\/mhj.2001.119423","article-title":"Congestive heart failure in pediatric patients","volume":"142","author":"Kay","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.07.725_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11936-004-0024-5","article-title":"Management of chronic congestive heart failure in children","volume":"6","author":"Balfour","year":"2004","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.jacc.2017.07.725_bib12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: a randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.07.725_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.07.725_bib14","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(89)90386-X","article-title":"The myocardium in congestive heart failure","volume":"63","author":"Katz","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.07.725_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.amjcard.2007.11.023","article-title":"Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers","volume":"101","author":"Flannery","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.07.725_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled trial","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.07.725_bib17","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.07.725_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF00798207","article-title":"Grading the severity of congestive heart failure in infants","volume":"13","author":"Ross","year":"1992","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacc.2017.07.725_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10928-015-9451-z","article-title":"Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessment","volume":"43","author":"Peigne","year":"2016","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.jacc.2017.07.725_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10928-015-9452-y","article-title":"Model-based approaches for ivabradine development in paediatric population, part II: PK and PK\/PD assessment","volume":"43","author":"Peigne","year":"2016","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.jacc.2017.07.725_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/euhj.2000.2399","article-title":"New normal limits for the paediatric electrocardiogram","volume":"22","author":"Rijnbeek","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.07.725_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4037\/15597768-1990-1013","article-title":"Using inotropic and vasodilating agents in pediatric patients with cardiac disease","volume":"1","author":"Delgizzi","year":"1990","journal-title":"AACN Clin Issues Crit Care Nurs"},{"key":"10.1016\/j.jacc.2017.07.725_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2174\/138955706777698598","article-title":"New inotropic pharmacologic strategies targeting the failing myocardium in the newborn and infant","volume":"6","author":"Veldman","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.jacc.2017.07.725_bib24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"Bohm","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.07.725_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2017.07.725_bib26","unstructured":"The Medical Dictionary for Regulatory Activities. Available at: https:\/\/www.meddra.org\/. Accessed July 20, 2017."},{"key":"10.1016\/j.jacc.2017.07.725_bib27","first-page":"CD007037","article-title":"Beta-blockers for congestive heart failure in children","author":"Frobel","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2017.07.725_bib28","first-page":"847","article-title":"Beta-adrenergic receptor antagonists and chronic heart failure in children","volume":"3","author":"Di Filippo","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jacc.2017.07.725_bib29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00392-014-0731-1","article-title":"The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy","volume":"103","author":"Parsons","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2017.07.725_bib30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.healun.2004.03.018","article-title":"International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children","volume":"23","author":"Rosenthal","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2017.07.725_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/CIRCULATIONAHA.113.003615","article-title":"Update on pharmacological heart failure therapies in children: do adult medications work in children and if not, why not?","volume":"129","author":"Rossano","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.07.725_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00246-012-0527-x","article-title":"The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study","volume":"34","author":"Huang","year":"2013","journal-title":"Pediatr Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717388150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717388150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T20:48:58Z","timestamp":1536180538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717388150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0735109717388150"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.07.725","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.07.725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}